Published in
Elsevier, Bioorganic and Medicinal Chemistry Letters, 11(5), p. 1125-1130, 1995
DOI: 10.1016/0960-894x(95)00178-v
Links
Tools
Active-site conformation of 17-(3-pyridyl)androsta-5,16-dien-3β-ol, a potent inhibitor of the P450 enzyme C17α-hydroxylase/C17-20 lyase
Journal article published in 1995 by
Df F. Burke 
,
Ca A. Laughton,
Cf F. Snook,
Stephen Neidle,
Ga A. Potter,
Michael Jarman
,
Ca A. Laughton,
Cf F. Snook,
Stephen Neidle,
Ga A. Potter,
Michael Jarman
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
17-(3-pyridyl)androsta-5,16-dien-3β-ol, a nanomolar inhibitor of the P450 enzyme C17α-hydroxylase/C17-20 lyase, is a target for prostate cancer chemotherapy. A model is presented for the inhibitor docked into the structure of the enzyme. © 1995.